Sign in
4

Changes in Ownership

Aquestive Therapeutics, Inc. Filed Acc 0001214659-22-013280

Options or other derivatives

  • SVP, Chief Commercial Officer acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Marshall Ken W. · SVP, Chief Commercial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-11-04 Grant or award : show line 1 in the form Non-Qualified Stock Option (right to buy) +40,000 40,000 D
Loading xslF345X03/marketforms-57372.xml…